Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Okroj

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Vaccine|October 30, 2007
Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individualsMarcin Okroj, O Brad Spiller, Zoltan Korodi, et al.
Arthritis Research & Therapy|October 8, 2016
The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritisAndré Struglics, Marcin Okroj, Per Swärd, et al.
Vaccine|December 8, 2010
Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parametersMarcin Okroj, Rosamaria Tedeschi, Roberta Mancuso, et al.
The Journal of Biological Chemistry|April 25, 2012
Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascadeMarcin Okroj, Emelie Holmquist, Jonatan Sjölander, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2006
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocciWojciech Kamysz, Carmela Silvestri, Oscar Cirioni, et al.
Plos One|August 7, 2008
C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3Leendert A Trouw, Marcin Okroj, Koba Kupreishvili, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalisMichal Potempa, Jan Potempa, Marcin Okroj, et al.
The Journal of Biological Chemistry|November 8, 2008
Characterization of the complement inhibitory function of rhesus rhadinovirus complement control protein (RCP)Marcin Okroj, Linda Mark, Anna Stokowska, et al.
Oncotarget|October 21, 2016
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancerAstrid Escudero-Esparza, Michael Bartoschek, Chrysostomi Gialeli, et al.
Cellular & Molecular Biology Letters|May 14, 2024
FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugsMonika Gorska-Arcisz, Marta Popeda, Marcin Braun, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Vaccine|October 30, 2007
Antibodies against Kaposi sarcoma-associated herpes virus (KSHV) complement control protein (KCP) in infected individualsMarcin Okroj, O Brad Spiller, Zoltan Korodi, et al.
Arthritis Research & Therapy|October 8, 2016
The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritisAndré Struglics, Marcin Okroj, Per Swärd, et al.
Vaccine|December 8, 2010
Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parametersMarcin Okroj, Rosamaria Tedeschi, Roberta Mancuso, et al.
The Journal of Biological Chemistry|April 25, 2012
Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascadeMarcin Okroj, Emelie Holmquist, Jonatan Sjölander, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2006
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocciWojciech Kamysz, Carmela Silvestri, Oscar Cirioni, et al.
Plos One|August 7, 2008
C4b-binding protein is present in affected areas of myocardial infarction during the acute inflammatory phase and covers a larger area than C3Leendert A Trouw, Marcin Okroj, Koba Kupreishvili, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalisMichal Potempa, Jan Potempa, Marcin Okroj, et al.
The Journal of Biological Chemistry|November 8, 2008
Characterization of the complement inhibitory function of rhesus rhadinovirus complement control protein (RCP)Marcin Okroj, Linda Mark, Anna Stokowska, et al.
Oncotarget|October 21, 2016
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancerAstrid Escudero-Esparza, Michael Bartoschek, Chrysostomi Gialeli, et al.
Cellular & Molecular Biology Letters|May 14, 2024
FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugsMonika Gorska-Arcisz, Marta Popeda, Marcin Braun, et al.
Pageof 3